Clinical Trial Detail

NCT ID NCT03654547
Title Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TransThera Biosciences Co., Ltd
Indications

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

TT-00420

Age Groups: adult senior

No variant requirements are available.